Fitgenes strives to provide premium health and wellness solutions using DNA and superior analytics and gives accredited practitioners advice around relevant, actionable interventions. The reports and associated interventions are designed to remain abreast of current literature in the area of nutrigenomics, epigenetics and personalised wellness.
Additionally Fitgenes, either directly or through its 100%-owned subsidiary GordianTec Pty Ltd, participates in multiple collaborative research programs to further knowledge in the areas of how our genes can influence health, wellbeing and sports performance, and the extent to which modification of gene expression by nutrigenomic, exercise or other interventions might overcome or enhance the impact of our genes.
Whilst Fitgenes is involved in new research, only published, peer-reviewed research informs the testing and reports we provide to practitioners.
GordianTec was established to commercialise work developed by Professor Grant Morahan and his team at The Harry Perkins Institute of Medical Research and The University of Western Australia. GordianTec’s focus is developing genetic tests for disease subtypes and genetic risk of disease. It was acquired by Fitgenes to develop the technology further, to support genetic management of health and wellness. Professor Morahan is the inaugural Professor of Diabetes Research at the University of Western Australia. He has made significant contributions to knowledge in three different fields: immunology (both molecular immunology and cellular immunology); genetics; and Type 1 diabetes. He has published over 200 research papers, including several seminal contributions in the highest impact journals (Nature, Science, Lancet, Nature Genetics, PNAS) and is the only Australian scientist with first author papers in all of these journals.
A collaboration including researchers from La Trobe University, Melbourne Australia, two Melbourne hospitals, researchers in Ireland and Fitgenes to review the impact of The Mediterranean diet on Non-Alcoholic Fatty Liver Disease.
A collaboration between the Auckland University of Technology, New Zealand, a NZ Medical Centre and Fitgenes to examine the association between Metabolic Syndrome parameters and AMY1 Gene Copy Number in Europeans, Maoris and Pacific peoples.
A multi-part study conducted by Monash and La Trobe Universities, Melbourne Australia, and Fitgenes examining the effect of genetic variations in the Vitamin D pathway on Vitamin D availability in the body and impacts on (variously) insulin management, obesity, Type-2 Diabetes and Metabolic Syndrome.
Several collaborative projects between Fitgenes and the School of Medicine, Nazarbayev University, Kazakhstan, including an examination of the application of nutrigenomics to treatment and prevention of Metabolic Syndrome and a study into the effects of genes variations in the Vitamin D pathway in Tuberculosis patients.
A La Trobe University, Melbourne Australia study on the effects of caffeine on soccer performance through genetic influences.